---

A study on the effect of Anti- VEGF on retinal venous occlusive disease with macular edema in a tertiary health care centre of southern Assam

---

Original Article

Author Details : Nilanjan Kaushik Thakur, Prasanna Jit Das*, Rajiv Kumar Das, Ankur Baruah, Choudhury Tufail Ahmed Saki, Devajit Deka

Volume : 9, Issue : 4, Year : 2023

Article Page : 570-576

https://doi.org/10.18231/j.ijceo.2023.108

Suggest article by email

Get Permission

---

Abstract

Background: Macular oedema is considered to be the primary reason for significant visual loss and impaired visual recovery in patients with retinal venous occlusion and rise in VEGF is strongly implicated in macular edema and as such there is a good rationale in treating these conditions with intravitreal anti-vascular endothelial growth factors. Aim of this study was to assess the effect of anti-VEGF (Bevacizumab) on retinal venous occlusive disease with macular edema.
Materials and Methods: This was prospective open label hospital based interventional study done from June 2021 to May 2022 in fifty eyes of fifty patients diagnosed with macular edema secondary to retinal venous occlusion and Snellen’s visual acuity at presentation of less than 6/12 were included in accordance with the inclusion and exclusion criteria.
Results: The results shows statistically significant improvement in mean central macular thickness and mean Snellen’s visual acuity at the end of 12 months and factors like Hypertension, Diabetes mellitus, Dyslipidemia and smoking are found to be highly associated with retinal venous occlusive diseases.
Conclusion: The intravitreal anti-VEGF (Bevacizumab) has been found to be effective in improving the macular edema and visual acuity in the study population with retinal venous occlusive diseases to a statistically significant level and that it was more pronounced in cases of BRVO, at the completion of the study period.
 

Keywords: Anti vascular endothelial growth factor (Anti- VEGF), Branch retinal vein occlusion (BRVO), Central retinal vein occlusion (CRVO), Retinal vein occlusion (RVO).

How to cite : Thakur N K, Das P J, Das R K, Baruah A, Saki C T A, Deka D, A study on the effect of Anti- VEGF on retinal venous occlusive disease with macular edema in a tertiary health care centre of southern Assam. Indian J Clin Exp Ophthalmol 2023;9(4):570-576

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.